Companies: 10,795·Total market cap: $144.5T
Nova Eye Medical Limited

Nova Eye Medical Limited

ELXMFOTCHealthcare● Active
$0.00
$-0.01(-86.72%)
Market Cap$541249
P/E Ratio
52W High$0.1
52W Low$0.0019

Nova Eye Medical Limited(ELXMF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ELXMF · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-062024-062023-062022-062021-06
Revenue
Revenue$29.27M$23.32M$17.02M$13.38M$13.39M
Cost of Revenue$10.38M$3.13M$16.18M$14.14M$11.63M
Gross Profit$18.89M$20.19M$0.84M($0.77M)$1.77M
Gross Margin %(computed)64.54%86.57%4.95%-5.72%13.20%
Operating Expenses
R&D Expenses$3.77M$4.54M$0.62M$0.28M$0.16M
G&A Expenses$1.85M$11.78M$11.26M$10.04M$7.87M
Total Operating Expenses$23.39M$29.16M$12.69M$9.12M$6.73M
Operating Income($4.50M)($8.97M)($11.85M)($6.59M)($4.96M)
Operating Margin %(computed)-15.39%-38.45%-69.60%-49.23%-37.07%
Interest Income$0.00M$0.12M$0.10M$0.03M$0.24M
Interest Expense$0.07M$0.07M$0.05M$0.06M$0.07M
Income Before Tax($9.06M)($8.79M)($17.00M)($7.82M)($5.25M)
Income Tax Expense$0.00M$0.00M($1.71M)($0.75M)($0.89M)
Net Income($9.06M)($8.79M)($15.29M)($7.50M)($4.36M)
Net Margin %(computed)-30.95%-37.68%-89.83%-56.03%-32.52%
Per Share & EBITDA
EPS (Basic)$-0.04$-0.04$-0.10$-0.05$-0.03
Wtd Avg Shares247.34M204.14M160.17M148.53M147.52M
EBITDA($6.72M)($5.98M)($9.48M)($7.89M)($3.45M)
EBITDA Margin %(computed)-22.97%-25.63%-55.69%-58.96%-25.76%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · AUD · M

深入了解Nova Eye Medical Limited

关于Nova Eye Medical Limited(ELXMF)损益表

Nova Eye Medical Limited(ELXMF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ELXMF实现营收$0.03B,毛利润$0.02B(毛利率64.54%),净利润($0.01B)(净利率-30.95%)。

常见问题

ELXMF · 4 问

Nova Eye Medical Limited(ELXMF)2025财年营收为$0.03B,同比up25.5%。

ELXMF revenueELXMF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09